C07K 14/7153
For colony-stimulating factors [csf]
Official title: {for colony-stimulating factors [CSF]}
C07K14/7153 (For colony-stimulating factors [csf]) appears on 51 US grants and 106 published applications in this corpus.
Search patents in C07K- Granted patents
- 51
- Published applications
- 106
- Assignees
- 76
- Inventors
- 277
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 4 | 1 |
| 2002 | 1 | 3 |
| 2003 | 1 | 3 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 4 |
| 2007 | 0 | 3 |
| 2008 | 0 | 0 |
| 2009 | 1 | 2 |
| 2010 | 0 | 3 |
| 2011 | 2 | 2 |
| 2012 | 1 | 1 |
| 2013 | 2 | 0 |
| 2014 | 0 | 2 |
| 2015 | 0 | 3 |
| 2016 | 2 | 2 |
| 2017 | 2 | 1 |
| 2018 | 2 | 7 |
| 2019 | 2 | 5 |
| 2020 | 2 | 5 |
| 2021 | 3 | 10 |
| 2022 | 3 | 10 |
| 2023 | 4 | 14 |
| 2024 | 5 | 9 |
| 2025 | 3 | 8 |
| 2026 | 6 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for constructing murine model with mutations in csflr gene and application thereof14 Jul 2026US 12,677,811 B2Beijing Tiantan Hospital, Capital Medical University
- Chimeric GMCSF-IL18 receptor2 Jun 2026US 12,643,936 B2St. Jude Children?S Research Hospital
- Compositions and methods for microglia replacement therapy28 Apr 2026US 12,612,599 B2Savanna Biotherapeutics, Inc.
- Compositions and methods for promoting hematopoietic cell cytotoxicity17 Feb 2026US 12,551,558 B2Children's Healthcare of Atlanta, Inc.
- Chimeric antigen receptor t lymphocyte for treating tumors, preparation method therefor, and use thereof17 Feb 2026US 12,552,852 B2Carbiogene Therapeutics Co., Ltd.
- Chimeric antigen receptors including jak/stat binding domains and modified immune cells10 Sep 2026US 2026/0265337 A1Carisma Therapeutics Inc.
- Csf-1r antibodies for the treatment of chronic graft versus host disease14 May 2026US 2026/0132210 A1Syndax Pharmaceuticals, Inc.
- Transplanting stem cell-derived microglia to treat leukodystrophies23 Apr 2026US 2026/0108560 A1The Regents of the University of California
- Methods of treating or preventing a complication of sickle cell disease5 Mar 2026US 2026/0061050 A1CSL Innovation Pty Ltd
- Pd-l1 variant immunomodulatory proteins and uses thereof5 Mar 2026US 2026/0062456 A1Alpine Immune Sciences, Inc.
Most cited
By later US patents
- Monoclonal antibody antagonists to IL-354US 6,177,078 B1Medvet Science Pty.Ltd. · 2001
- Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules48US 8,080,246 B2Five Prime Therapeutics, Inc. · 2011
- Soluble extracellular domain of human M-CSF receptor47US 6,184,354 B2Chiron Corporation · 2001
- Crystallization of M-CSF.alpha.46US 5,866,114 AChiron Corporation · 1999
- Receptor derived peptides as modulators of receptor activity40US 6,333,031 B1Reception, Inc. · 2001